Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells

Open access
Ruan, H, Zhan, Y Y, Hou, J, Xu, B, Chen, B, Tian, Y, Wu, D, Zhao, Y, Zhang, Y, Chen, X, Mi, P, Zhang, L, Zhang, S, Wang, X, Cao, H, Zhang, W, Wang, H, Li, H, Su, Y, Zhang, X K, Hu, T · 2017 · Oncogene

Abstract

Berberine, an isoquinoline alkaloid, is a traditional oriental medicine used to treat diarrhea and gastroenteritis. Recently, we reported that it could inhibit the growth of intestinal polyp in animals and in patients with the familial adenomatous polyposis by downregulating β-catenin signaling. However, the intracellular target mediating the effects of berberine remains elusive. Here, we provide evidence that berberine inhibits β-catenin function via directly binding to a unique region comprising residues Gln275, Arg316 and Arg371 in nuclear receptor retinoid X receptor alpha (RXRα), where berberine concomitantly binding to and synergistically activating RXRα with 9-cis-retinoic acid (9-cis-RA), a natural ligand binding to the classical ligand-binding pocket of RXRα. Berberine binding promotes RXRα interaction with nuclear β-catenin, leading to c-Cbl mediated degradation of β-catenin, and consequently inhibits the proliferation of colon cancer cells. Furthermore, berberine suppresses the growth of human colon carcinoma xenograft in nude mice in an RXRα-dependent manner. Together, our study not only identifies RXRα as a direct protein target for berberine but also dissects their binding mode and validates that berberine indeed suppresses β-catenin signaling and cell growth in colon cancer via binding RXRα, which provide new strategies for the design of new RXRα-based antitumor agents and drug combinations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/onc.2017.296

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 158

Metadata

Authors
Ruan, H., Zhan, Y. Y., Hou, J., Xu, B., Chen, B., Tian, Y., Wu, D., Zhao, Y., Zhang, Y., Chen, X., Mi, P., Zhang, L., Zhang, S., Wang, X., Cao, H., Zhang, W., Wang, H., Li, H., Su, Y., Zhang, X. K., & Hu, T.
Venue
Oncogene
Published
2017-08-28
Volume
36
Issue
50
Pages
6906-6918
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2746036157
Cited by
158
References
3
FWCI
10.63
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells. https://app.cochat.ai/papers/10.1038/onc.2017.296
The paper
Ruan, H., Zhan, Y. Y., Hou, J., Xu, B., Chen, B., Tian, Y., Wu, D., Zhao, Y., Zhang, Y., Chen, X., Mi, P., Zhang, L., Zhang, S., Wang, X., Cao, H., Zhang, W., Wang, H., Li, H., Su, Y., . . . Hu, T. (2017). Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells. Oncogene. https://doi.org/10.1038/onc.2017.296

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.